Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Puretech Health Plc ADR (NQ: PRTC )

21.27 +0.58 (+2.80%)
Streaming Delayed Price Updated: 9:38 AM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Puretech Health Plc ADR

< Previous 1 2 3 4 5 6 Next >
PureTech’s LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers
From PureTech Health plc
Via Business Wire
PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference
From PureTech
Via Business Wire
PureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meeting
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health Monitoring
From PureTech Health plc
Via Business Wire
PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech’s Glyph™ Platform
From PureTech Health plc
Via Business Wire
PureTech to Present at Two Upcoming Investor Conferences
From PureTech Health plc
Via Business Wire
PureTech to Present at the Jefferies London Healthcare Conference
From PureTech Health plc
Via Business Wire
PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference
From PureTech Health plc
Via Business Wire
PureTech to Present at the Morgan Stanley Global Healthcare Conference
From PureTech Health plc
Via Business Wire
PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting Design of Dose-Ranging Trial in Idiopathic Pulmonary Fibrosis (IPF) at European Respiratory Society International Congress 2022
From PureTech Health
Via Business Wire
PureTech Health plc – Half-Year Report
From PureTech
Via Business Wire
PureTech Founded Entity Sonde Health Announces Multi-Year Partnership with Koye Pharmaceuticals
From PureTech Health plc
Via Business Wire
PureTech Health: Notice of Half-Yearly Results
From PureTech Health
Via Business Wire
PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Akili Announces Public Company Board of Director Nominees
From PureTech Health plc
Via Business Wire
PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb)
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Vedanta Biosciences Unveils State-of-the-Art Manufacturing Facility to Provide Clinical and Commercial Supply of Oral Therapies Based on Defined Bacterial Consortia
From PureTech Health plc
Via Business Wire
Results of Annual General Meeting
From PureTech Health plc
Via Business Wire
PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300
From PureTech Health plc
Via Business Wire
PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute “Long” COVID with Respiratory Complications
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
From PureTech Health plc
Via Business Wire
PureTech to Present at the Jefferies Healthcare Conference
From PureTech Health
Via Business Wire
PureTech Founded Entity Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Vedanta Biosciences Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
From PureTech Health plc
Via Business Wire
Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
From Vedanta Biosciences
Via Business Wire
PureTech to Present at the UBS Global Healthcare Conference
From PureTech Health plc
Via Business Wire
PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022
From PureTech Health plc
Via Business Wire
PureTech Announces Share Buyback Program Update
From PureTech Health plc
Via Business Wire
PureTech Announces Share Buyback Program of up to $50 Million
From PureTech Health plc
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.